GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Kennedy Capital Management LLC

Kennedy Capital Management LLC cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 117,309 shares of the company's stock after selling 4,265 shares during the quarter. Kennedy Capital Management LLC's holdings in GE HealthCare Technologies were worth $9,171,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. CoreFirst Bank & Trust purchased a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $25,000. Runnymede Capital Advisors Inc. acquired a new stake in GE HealthCare Technologies during the fourth quarter worth about $28,000. Continuum Advisory LLC boosted its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares during the period. Bank of Jackson Hole Trust bought a new position in GE HealthCare Technologies in the 4th quarter valued at about $32,000. Finally, OFI Invest Asset Management acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $34,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock traded down $1.14 on Wednesday, hitting $61.96. 2,340,993 shares of the company were exchanged, compared to its average volume of 3,145,974. The company has a 50-day moving average price of $80.78 and a 200 day moving average price of $83.66. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $28.37 billion, a price-to-earnings ratio of 14.31, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is currently 3.23%.

Analyst Ratings Changes

A number of analysts recently issued reports on GEHC shares. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $97.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.